SCHEMBL6096397

SCHEMBL6096397

COc1ccc2[nH]c(C)c(C3=C(O)C(=O)C=C(O)C3=O)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
AKR1C2 P52895 1/20 0.45
HPGD P15428 2/20 0.45
CCNB2 O95067 2/20 0.45
CDK1 P06493 2/20 0.45
CCNB1 P14635 2/20 0.45
GSK3A P49840 2/20 0.45
GSK3B P49841 2/20 0.45
CDK5 Q00535 2/20 0.45
CDK5R1 Q15078 2/20 0.45
CCNB3 Q8WWL7 2/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
GFER P55789 2/20 0.45
HTR6 P50406 2/20 0.45
HTR7 P34969 1/20 0.45
PIK3CA P42336 1/20 0.44
MTOR P42345 1/20 0.44
PIK3CG P48736 1/20 0.44
KDM4E B2RXH2 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7234412 0.87 ALDH1A1 (0.51) ALDH1A1AKR1C2HPGDCCNB2CDK1
SCHEMBL6093757 0.85 ALDH1A1 (0.42) ALDH1A1HPGDGSK3AGSK3BCDK5
SCHEMBL6094945 0.83 MAP3K14 (0.44) HPGDGSK3AGSK3BHTR6HTR7
SCHEMBL6110147 0.80 CCR6 (0.51) ALDH1A1HPGDGSK3BMEN1KMT2A
SCHEMBL6096320 0.78 MITF (0.43) ALDH1A1MAPT
SCHEMBL6096465 0.77 KDR (0.50) ALDH1A1MEN1KMT2AHTR6HTR7
SCHEMBL7230623 0.76 MAP2 (0.50) ALDH1A1AKR1C2HPGDGSK3AGSK3B
SCHEMBL6098106 0.76 ALDH1A1 (0.45) ALDH1A1AKR1C2HPGDCCNB2CDK1
SCHEMBL29094076 0.74 HKDC1 (0.64) ALDH1A1AKR1C2HPGDMEN1KMT2A
SCHEMBL6095842 0.70 RPA1 (0.43) HPGDMEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA ALDH1A1 609/4885AKR1C2 1539/4885HPGD 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.